Michael Lind

4.9k total citations
118 papers, 3.6k citations indexed

About

Michael Lind is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Michael Lind has authored 118 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 40 papers in Pulmonary and Respiratory Medicine and 33 papers in Molecular Biology. Recurrent topics in Michael Lind's work include Lung Cancer Treatments and Mutations (20 papers), Lung Cancer Research Studies (16 papers) and Chemotherapy-induced organ toxicity mitigation (14 papers). Michael Lind is often cited by papers focused on Lung Cancer Treatments and Mutations (20 papers), Lung Cancer Research Studies (16 papers) and Chemotherapy-induced organ toxicity mitigation (14 papers). Michael Lind collaborates with scholars based in United Kingdom, United States and Australia. Michael Lind's co-authors include Lynn Cawkwell, Philip Drew, Laura Smith, Lawrence K. Duffy, Daniel A. Kirschner, Dennis J. Selkoe, Hideyo Inouye, Alison J. Sinclair, Mark B. Watson and Sara L. O’Kane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Lind

113 papers receiving 3.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael Lind 1.3k 1.3k 689 476 420 118 3.6k
Brian Booth 1.6k 1.2× 1.3k 1.0× 699 1.0× 376 0.8× 277 0.7× 77 4.6k
R. Donald Harvey 1.9k 1.5× 1.8k 1.4× 760 1.1× 263 0.6× 356 0.8× 167 4.8k
Massimo Zucchetti 1.8k 1.4× 1.9k 1.5× 579 0.8× 226 0.5× 308 0.7× 170 4.8k
Sanjay Goel 1.7k 1.3× 2.9k 2.3× 879 1.3× 208 0.4× 411 1.0× 269 5.2k
Cody J. Peer 1.8k 1.3× 1.5k 1.2× 559 0.8× 138 0.3× 450 1.1× 156 4.0k
David M. Vigushin 2.3k 1.7× 806 0.6× 309 0.4× 496 1.0× 205 0.5× 42 3.9k
W P Steward 1.1k 0.9× 929 0.7× 383 0.6× 232 0.5× 250 0.6× 49 2.9k
Lionel D. Lewis 1.4k 1.1× 1.7k 1.4× 806 1.2× 124 0.3× 352 0.8× 167 4.2k
Winston Tan 873 0.7× 1.4k 1.1× 1.1k 1.5× 416 0.9× 351 0.8× 117 3.6k
Enrique Espinosa 1.5k 1.2× 1.8k 1.4× 773 1.1× 200 0.4× 223 0.5× 232 4.2k

Countries citing papers authored by Michael Lind

Since Specialization
Citations

This map shows the geographic impact of Michael Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lind more than expected).

Fields of papers citing papers by Michael Lind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lind. The network helps show where Michael Lind may publish in the future.

Co-authorship network of co-authors of Michael Lind

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lind. A scholar is included among the top collaborators of Michael Lind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lind. Michael Lind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Greenley, Sarah, et al.. (2022). Geographical distance and reduced access to palliative radiotherapy: systematic review and meta-analysis. BMJ Supportive & Palliative Care. 14(e1). e89–e98. 6 indexed citations
3.
4.
Hodgson, Susan, et al.. (2020). 60P Real-world experience of immunotherapy in elderly cancer patients in a UK cancer centre. Annals of Oncology. 31. S1439–S1440. 1 indexed citations
5.
Spencer, Katie, Ruth H. Jack, Andrew Bates, et al.. (2017). P3.07-011 Geographical Variation in the Use of Radiotherapy and Surgical Resection for Treatment of Non-Small Cell Lung Cancer in England. Journal of Thoracic Oncology. 12(1). S1436–S1437.
6.
Lind, Michael, et al.. (2017). PUB068 The Applicability of Comorbidity Indices in Predicting Chemo toxicity in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S1487–S1488. 1 indexed citations
7.
Lüchtenborg, Margreet, et al.. (2015). Effect of Comorbidity on Surgery and Survival Among Lung Cancer Patients in England. Annals of Oncology. 26. i18–i18. 1 indexed citations
8.
Garimella, Veerabhadram, John Fox, Peter Kneeshaw, et al.. (2014). Clinical response to primary letrozole therapy in elderly patients with early breast cancer: Possible role for p53 as a biomarker. International Journal of Surgery. 12(8). 821–826. 4 indexed citations
9.
Lüchtenborg, Margreet, Sharma P. Riaz, Victoria H. Coupland, et al.. (2013). High Procedure Volume Is Strongly Associated With Improved Survival After Lung Cancer Surgery. Journal of Clinical Oncology. 31(25). 3141–3146. 153 indexed citations
10.
Elfadl, Dalia, et al.. (2011). Repeatedly identified differentially expressed proteins (RIDEPs) from antibody microarray proteomic analysis. Journal of Proteomics. 74(5). 698–703. 11 indexed citations
11.
12.
Eagle, Gina, et al.. (2010). Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: Current status. Cancer Letters. 294(1). 13–24. 30 indexed citations
13.
Manton, D J, A. Chaturvedi, Anne M. Hubbard, et al.. (2006). Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. British Journal of Cancer. 94(3). 427–435. 152 indexed citations
14.
Raymond, Éric, Svein Dueland, Michael Lind, et al.. (2005). Pharmacokinetics of a nucleoside analogue CP-4055 in two phase I trials using a daily for 5 days schedule and three intermittent weekly or biweekly schedules. Cancer Research. 65. 936–936. 2 indexed citations
15.
Nix, Paola, Michael Lind, John Greenman, N. Stafford, & Lynn Cawkwell. (2004). Expression of Cox-2 protein in radioresistant laryngeal cancer. Annals of Oncology. 15(5). 797–801. 40 indexed citations
16.
Cowen, Michael E., et al.. (2004). Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation. British Journal of Cancer. 90(4). 900–905. 34 indexed citations
17.
Cawkwell, Lynn, et al.. (2002). Karyotypic variation between independently cultured strains of the cell line MCF-7 identified by multicolour fluorescence in situ hybridization. International Journal of Oncology. 20(3). 489–94. 38 indexed citations
18.
Lind, Michael, Denis J. Murphy, H.L. Sharma, et al.. (1991). Comparative intraperitoneal pharmacokinetics of three platinum analogues. Cancer Chemotherapy and Pharmacology. 28(4). 315–317. 9 indexed citations
19.
Lind, Michael, et al.. (1990). The effect of route of administration and fractionation of dose on the metabolism of ifosfamide. Cancer Chemotherapy and Pharmacology. 26(2). 105–111. 50 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Booth Breakdown of academic impact, for papers by R. Donald Harvey Breakdown of academic impact, for papers by Massimo Zucchetti Breakdown of academic impact, for papers by Sanjay Goel Breakdown of academic impact, for papers by Cody J. Peer Breakdown of academic impact, for papers by David M. Vigushin Breakdown of academic impact, for papers by W P Steward Breakdown of academic impact, for papers by Lionel D. Lewis Breakdown of academic impact, for papers by Winston Tan Breakdown of academic impact, for papers by Enrique Espinosa
Rankless by CCL
2026